Starpharma is on innovative biotechnology company with a mission to help patients with significant illnesses (eg, cancer) achieve improved health outcomes and quality of life by applying our unique dendrimer technology.
With a long history of developing assets and partnering, we lay a strong foundation for driving growth and delivering returns to shareholders. Our focus is on advancing our product pipeline through continued research and development, aiming to address unmet medical needs and explore new commercial opportunities globally. We are committed to innovation in dendrimer-based technologies, positioning us at the forefront of biotechnology advancements in Australia.
Source: Great Place To Work® 2024 Australia National Employee Engagement Study
Start by earning Great Place To Work-Certified™ status through the Trust Index™ employee survey and the Culture Brief. Once Certified, eligible organizations are considered for Best Workplaces™ lists during the qualification period.
Best Workplaces™ recognition is based on employee feedback collected through the Trust Index™ survey, supported by your Culture Brief submission. This keeps the focus on the real employee experience rather than marketing claims.
Eligibility starts with becoming Great Place to Work-Certified™. Your organization also needs to meet the list’s timing and participation requirements, so your results fall within the qualification window for that Best Workplaces™ list.
The Culture Brief is a short questionnaire about your organization to support your survey results. The Culture Audit goes deeper, typically asking for more detailed descriptions and evidence of your workplace practices.
